T he CTNNB1 gene encodes the beta-catenin protein, which is a key transcriptional co-activator of the Wnt/b-catenin signaling pathway and is essential for embryonic development, adult tissue homeostasis, stem cell regulation, and tumorigenesis. 1 Somatic mutations in CTNNB1 have been reported to be associated with many types of cancer, and germline mutations in the gene have been identified in patients with intellectual disabilities [2] [3] [4] [5] [6] [7] [8] and autism spectrum disorders 9,10 involving multitissue phenotypes. [11] [12] [13] Of these patients, 50% display abnormalities in vision, including strabismus, 6, 13 hyperopia, 6 myopia, 6 retinal detachment, 14 and lens and vitreous opacities. 14 Recently , mutations in CTNNB1 have been reported to lead to familial exudative vitreoretinopathy (FEVR) with or without extraocular manifestations. 15 FEVR is a genetic disorder characterized by abnormalities in peripheral retinal vascularization and exhibits both clinical and genetic heterogeneity. The phenotypes of FEVR vary widely, from normal visual acuity with only mild nonperfusion zone in the peripheral retina, as demonstrated by fundus fluorescein angiography, to blindness resulting from retinal detachment. 16 FEVR mostly occurs alone (nonsyndromic) but also can be accompanied by systemic abnormalities, including mental retardation, microcephaly, and osteoporosis and osteopenia (syndromic). [17] [18] [19] In addition, FEVR can occur in an autosomal dominant, autosomal recessive, or X-linked manner, and several genes, including FZD4, 20 LRP5, 18 TSPAN12, 21 and NDP, 22 which are involved in the Wnt/b-catenin signaling pathway, and KIF11, 17 have been reported to cause FEVR. Mutations in NDP can cause both FEVR and Norrie disease, 22 which involves similar vascular dysgenesis of the retina accompanied by microphthalmia, corneal opacity, iris synechia, and mental disorders. Mutations in KIF11 can cause both nonsyndromic and syndromic FEVR, 17 involving microcephaly and mental retardation, and mutations in the other three genes cause nonsyndromic FEVR. Three heterozygous mutations in CTNNB1 were recently identified in probands with FEVR: one is associated with syndromic FEVR, and the other two are associated with nonsyndromic FEVR. 15 Here, we investigated pathogenic variants in CTNNB1 in 3280 probands with hereditary eye diseases, including 106 probands with FEVR, based on exome sequencing. The results will extend our knowledge of the mutational frequency and spectrum of CTNNB1, as well as the potential genotypephenotype correlations.
MATERIALS AND METHODS
A total of 3280 unrelated probands with different hereditary eye diseases (106 probands with FEVR and 3174 probands with other genetic eye diseases, including retinal degeneration, high myopia, glaucoma, hyperopia, and ocular dysplasia) were recruited to participate in this study. Peripheral blood samples and clinical data were collected from each proband, and genomic DNA was obtained from leucocytes isolated from the peripheral blood samples. In accordance with the tenets of the Declaration of Helsinki, written informed consent was obtained from all the participants or their guardians before the study. This study was approved by the Institutional Review Board of the Zhongshan Ophthalmic Center.
Whole-exome sequencing of the genome of all 3280 probands was performed by Macrogen (http://www.macro gen.com/en/main/index.php). In brief, genomic DNA from each proband was captured using an Agilent SureSelect Human All Exon Enrichment V5 Kit (50M; Agilent, Santa Clara, CA, USA), and the exome-enriched DNA fragments were then sequenced using the Illumina HiSeq4000 system (Illumina, San Diego, CA, USA). The average sequencing depth was at least 125-fold. Variant calling and annotation were performed using SAMtools (http://samtools.sourceforge.net/) and ANNOVAR (http://annovar.openbioinformatics.org/en/latest/), respectively.
The variants in CTNNB1 were selected and analyzed through a multistep bioinformatics analysis as follows: lowcertainty variant positions with coverage less than 10 were excluded; variants with a minor allele frequency ‡0.01, as determined based on the dbSNP database, 1000 Human Genome Project, Exome Variant Server (EVS), and Exome Aggregation Consortium (ExAC, Cambridge, MA, USA; http:// exac.broadinstitute.org; accessed October 15, 2018), were excluded; the variants in noncoding regions and synonymous variants without a splice site change, as determined according to the Berkeley Drosophila Genome Project (in the public domain, http://www.fruitfly.org/) or NetGene2 (http://www. cbs.dtu.dk/services/NetGene2/), were excluded; the variants predicted to be benign by two online tools, PolyPhen-2 (http:// genetics.bwh.harvard.edu/pph2/) and SIFT (http://sift.jcvi. org), were excluded; and the pathogenic variants identified through a comparative analysis of variants among different groups of diseases were filtered.
A review of the mutations and phenotypes of CTNNB1 was performed to detect potential genotype-phenotype correlations.
RESULTS
A total of 11 rare variants that potentially affect the coding regions of CTNNB1 were detected in 11 of the 3280 samples, and these consisted of 5 missense variants, 2 splicing variants, 2 nonsense variants, and 2 frameshift variants. The five missense variants were identified in four patients with glaucoma and one patient with high myopia, whereas the two splicing variants were identified in one patient with retinitis pigmentosa and one patient with high myopia ( Supplementary Table S1 ). The two potentially pathogenic frameshift variants (c.1104delT, p.His369Thrfs*2 and c.1738_1742delinsACA, p.Leu580Thrfs*28) were identified in two probands with FEVR or Norrie-like retinopathy, and the two potentially pathogenic nonsense variants (c.999del, p.Tyr333* and c.1867C>T, p.Gln623*) were identified in two probands with Norrie-like retinopathy ( Table  1 ). The four mutations were classified as loss-of-function (LoF) mutations resulting in protein truncation. 23 This type of mutation is extremely rare in CTNNB1, as determined by a review of the ExAC database (http://exac.broadinstitute.org/ gene/ENSG00000168036; October 15, 2018) . Three of the four mutations are de novo mutations, and the status of the remaining mutation is unknown because of the unavailability of genomic DNA from the parents.
The clinical manifestations of the four patients are summarized in Table 2 . All four patients were examined before the age of 1 year, and they showed typical temporal dragging of the optic disc or retinal detachment accompanied by a retrolenticular fibrotic mass ( Fig. 1, Supplementary Fig. S1 ). Three of the four patients showed signs of Norrie disease, including microphthalmia, corneal opacity, microcornea, posterior synechia of iris, or pupil occlusion ( Table 2) . After the molecular results were obtained, the four families were recontacted. Three of the four probands showed systemic anomalies, as determined via telephone surveys, and the remaining proband was lost to follow-up. The proband QT2648, who is currently 15 months of age, had scoliosis and experienced difficulty in controlling her head. She was also unable to speak, and a cranial computed tomography scan taken when she was 5 months of age showed a local osteolysis lesion on the left parietal, as determined by a review of her medical records. Both proband QT1615 and QT1504 are currently 4 years of age and exhibit autism and learning disabilities. QT1615 showed microcephaly, with a head circumference of 40 cm, when she was 9 months of age.
Since mutations in CTNNB1 were identified in patients with intellectual disabilities in 2012, 2 45 mutations have been identified in 56 families with variable diagnoses and phenotypes ( Supplementary Table S2 ). [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [24] [25] [26] [27] The mutation types and locations in the 56 families with or without eye abnormalities are shown in Figure 2 .
DISCUSSION
In this study, four truncating mutations in CTNNB1 were identified in four patients with syndromic FEVR or Norrie disease but not in patients with other eye diseases. These results provide additional evidence for an association of truncating mutations in CTNNB1 with FEVR or Norrie-like retinopathy.
Nonsense and frameshift mutations in CTNNB1 are associated with FEVR because of several points. First, the same type of mutations in CTNNB1 were identified in four unrelated patients with the same class of diseases, namely, FEVR or Norrie-like retinopathy. Second, neither nonsense nor frameshift mutations in CTNNB1 were detected in more than 3000 in-house control individuals in our laboratory or more than 60,000 individuals in the ExAC database. Third, three of the four mutations are de novo, and fourth, all four mutations in CTNNB1 identified in the current study are LoF mutations, which is consistent with the previous finding that most (92.7%, 38/41) mutations in the gene are LoF mutations (Supplementary Table S2 ). Moreover, this type of mutation results in the haploinsufficiency of CTNNB1 by nonsense-mediated mRNA decay 3 and a conditional knockout mouse model of ctnnb1 established in previous studies showed specific vascular defects in the central nervous system and retina due to bcatenin depletion. 28, 29 To date, 45 mutations in CTNNB1 have been identified. With the exception of 3 missense mutations, most of these 45 mutations are truncating mutations (42/45), including 22 nonsense mutations, 15 frameshift mutations, 3 splicing mutations, and 2 gross deletion mutations. The 45 mutations are located in all three domains of the gene, including the four mutations identified in the current study, which are found in the armadillo repeat domain (ARM) (Fig. 2) . Twenty-nine mutations are associated with eye abnormalities, and eight mutations can cause nonsyndromic or syndromic FEVR. Nevertheless, there are no differences in the types or locations between mutations associated with eye abnormalities and mutations not associated with eye abnormalities. Of the eight mutations associated with FEVR and Norrie-like retinopathy, five are located in the ARM, the other three are located in the carboxy-terminal domain, and none are located in the aminoterminal domain (Fig. 2) . However, a clear genotype-phenotype correlation cannot be obtained due to the small number of cases with FEVR and the lack of a detailed fundus description for most patients with CTNNB1 mutations.
Most mutations (38/41) in CTNNB1 were identified in 48 families with intellectual disabilities and autism spectrum disorders in previous studies. Of the 48 families, approximately half (20/48) had eye abnormalities. Three mutations in CTNNB1 were recently identified in eight patients with FEVR from three families, and one of these patients was diagnosed with FEVR at the age of 4 weeks but displayed features of intellectual disability at the age of 3 years. 15 In the current study, four patients with CTNNB1 mutations exhibited FEVR or Norrie-like retinopathy, and all of them were examined before 1 year of age due to severe visual defects. The follow-up study after the molecular results were obtained showed that three of the four patients exhibited features of systemic anomalies, including autism, learning disability, motor delay, and scoliosis. The other patient was not available (QT409) but displayed features of Norrie disease. In addition to this study, two previous studies identified two mutations in patients with FEVR or retinal detachment accompanied by intellectual disability, developmental delay, and microcephaly. 14, 24 Therefore, variable manifestations of FEVR might be part of the phenotypes resulting from CTNNB1 mutations. This trend is similar to that found for mutations in KIF11, which have been identified in patients with syndromic and nonsyndromic FEVR. Some patients with mutations in KIF11 are initially diagnosed with FEVR but found to exhibit mental retardation or microcephaly when reexamined after 17 years of age, potentially because intellectual disability is easily ignored in infants. Moreover, Norrie disease is characterized by fibrovascular masses secondary to similar vascular dysgenesis of the retina accompanied by mental disorders. Mutations in NDP can cause Norrie disease, and occasionally FEVR. Therefore, similar phenotypes can be caused by mutations in CTNNB1, KIF11, and NDP.
In conclusion, we identified four heterozygous truncating mutations in CTNNB1 in patients with syndromic FEVR or Norrie disease. Our results provide additional evidence for an association between CTNNB1 haploinsufficiency and autosomal dominant syndromic FEVR or Norrie disease. Furthermore, mutations in CTNNB1, KIF11, or NDP might cause similar or overlapping phenotypes, but the mechanism needs to be studied further.
